Tridacaine Ii Patch
Product Images NDC 73352-830

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tridacaine Ii (NDC 73352-830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trifluent Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tridacaine 01)

Chemical structure diagram of Lidocaine, showing its molecular components arranged with a benzene ring substituted with methyl groups and an amide linkage to a diethylaminoethyl group.*

FDA Label Image

Figure 1 (Tridacaine 02)

A line graph showing plasma lidocaine concentration (ng/mL) over time (hours) for the drug Tridacaine II lidocaine topical patch. The graph displays cyclic peaks and troughs in plasma lidocaine levels across a 72-hour period, with peak concentrations occurring approximately every 24 hours.*

FDA Label Image

Principal Display Panel (15 Patch Pouch Label)

Label for Tridacaine II Lidocaine Patch 5%, a topical prescription drug by Trifluent Pharma LLC. Each adhesive patch contains 700 mg lidocaine (50 mg/g). The package includes 15 patches in 15 envelopes. The label lists inactive ingredients, storage instructions, and a warning to keep patches away from children and pets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.